Biotechnology Jobs

GSK · USA - Pennsylvania - Upper Providence · US$340,500 – US$567,500 pa

Leads global development of a cancer vaccine asset from late-stage transition through approval and launch, acting as single point of accountability. Builds and directs a matrix Medicine Development Team spanning clinical development, immunology, manufacturing, regulatory, safety, medical affairs and commercial, and drives strategy, go/no-go decisions and lifecycle planning.

GSK · London

Builds and maintains financial and operational models, forecasts and dashboards that guide R&D portfolio and investment decisions, including NPV/rNPV, scenario and sensitivity analysis and Monte Carlo simulation. Works with the Head of Data Science and the Finance Portfolio Analytics Manager, turning scientific, clinical, financial and operational data into clear outputs for review discussions.

CSL · Opfikon, Switzerland

Leads strategic sourcing and evaluation of late-stage external clinical assets in Immunology, from Phase 2 through marketed drugs. Sits on the Therapy Area Leadership Team, co-leads New Product Opportunity reviews, engages external KOLs and investigators, and drives cross-functional due diligence with BD to close deals.

CSL · Maidenhead

Leads strategic sourcing and evaluation of late-stage external clinical assets in Immunology, from Phase 2 through marketed drugs, as the senior S&E leader within the Therapy Area Leadership Team. Drives proactive sourcing, cross-functional due diligence, and KOL engagement, partnering with BD to advance high-priority opportunities through negotiation and deal close.

SRG · Darlington · £65,000 – £85,000 pa

Lead multidisciplinary operational teams across two sites, covering operations, engineering, facilities and site services. Drive continuous improvement, GMP and H&S compliance, facilities management, budgets and capital projects supporting biologics, RNA and medicines manufacturing. Senior leadership role shaping facility strategy and operational capability.

Bicycle Therapeutics · Cambridge

Operational backbone of R&D Quality, administering and optimising a validated eQMS (Veeva, TrackWise, Dot Compliance) for GxP document control, training matrices, deviation/CAPA tracking and inspection readiness. Supports FDA, MHRA and EMA inspections and works across clinical, non-clinical and pharmacovigilance teams.

Moderna · London

Lead CMC regulatory strategy for UK-manufactured and UK-licensed mRNA products across development, registration and post-approval lifecycle. Act as primary point of contact with the MHRA, oversee submissions and manufacturing change assessments, and shape global regulatory approaches across cross-functional matrix teams.

Evotec · Abingdon

Owns Evotec's in silico therapeutics design capability, uniting computational chemistry, generative and modality design (small molecules, peptides, protein engineering, degraders, molecular glues) and predictive ADMET/safety under one mandate. A newly created unit within the In Silico & AI group with an explicit build mandate: set technical vision, grow a multi-site team, and industrialise repeatable, benchmarked methods across partner programmes.

Evotec · Abingdon

Acts as the single front door between Global Biology Operations and the In Silico & AI organisation, owning demand, the in silico roadmap and delivery orchestration across computational biology, bioinformatics and AI teams. Focuses on Disease-to-Target and applying the proprietary E.MPD multi-omics resource to target identification, validation and patient stratification, while evidencing value and supporting client proposals.

Relation Therapeutics · London

Lead clinical pharmacology and pharmacometrics across a growing drug discovery portfolio, serving as the quantitative lead on cross-functional project teams. Apply MIDD, PBPK, population PK/PD and QSP modelling to translate nonclinical data into human dosing and trial design, spanning small molecules, biologics and novel platforms. Also manages CRO partnerships and authors regulatory submissions.